Evidence map›Paper›PMID 22802611›Full record

ArticlePlant physiology2012

A mathematical model for BRASSINOSTEROID INSENSITIVE1-mediated signaling in root growth and hypocotyl elongation.

G Wilma van Esse, Simon van Mourik, Hans Stigter, Colette A ten Hove, Jaap Molenaar, Sacco C de Vries

Abstract read
In one paragraph

Article in Plant physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Moonlighting Proteins Shine New Light on Molecular Signaling Niches.International journal of molecular sciences · 2021
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

G Wilma van EsseDepartment of Biochemistry, Wageningen University, 6703 HA Wageningen, The Netherlands. wilma.vanesse@wur.nl
Simon van Mourik
Hans Stigter
Colette A ten Hove
Jaap Molenaar
Sacco C de Vries

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brassinosteroid (BR) signaling is essential for plant growth and development. In Arabidopsis (Arabidopsis thaliana), BRs are perceived by the BRASSINOSTEROID INSENSITIVE1 (BRI1) receptor. Root growth and hypocotyl elongation are convenient downstream physiological outputs of BR signaling. A computational approach was employed to predict root growth solely on the basis of BRI1 receptor activity. The developed mathematical model predicts that during normal root growth, few receptors are occupied with ligand. The model faithfully predicts root growth, as observed in bri1 loss-of-function mutants. For roots, it incorporates one stimulatory and two inhibitory modules, while for hypocotyls, a single inhibitory module is sufficient. Root growth as observed when BRI1 is overexpressed can only be predicted assuming that a decrease occurred in the BRI1 half-maximum response values. Root growth appears highly sensitive to variation in BR concentration and much less to reduction in BRI1 receptor level, suggesting that regulation occurs primarily by ligand availability and biochemical activity.

Indexed as

Models, TheoreticalSignal TransductionArabidopsisArabidopsis ProteinsBrassinosteroidsComputational BiologyCulture MediaGreen Fluorescent ProteinsHypocotylLigandsPlant RootsProtein KinasesReceptors, Cell SurfaceSteroids, HeterocyclicTriazolesArabidopsis ProteinsbrassinazolebrassinolideBrassinosteroidsBRI1 protein, ArabidopsisCulture MediaGreen Fluorescent ProteinsLigandsProtein KinasesReceptors, Cell SurfaceSteroids, HeterocyclicTriazoles

Identifiers

PMID22802611
PMCPMC3440225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.